Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)
Pericarditis, a clinical syndrome characterized by inflammation and thickening of the pericardium, is one of the most common forms of inflammatory diseases of the cardiovascular system. The most common and severe complication of acute pericarditis is idiopathic recurrent pericarditis (IRP), which ha...
Main Authors: | E. L. Nasonov, Z. N. Sukmarova, T. V. Popkova, B. S. Belov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2023-03-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/3278 |
Similar Items
-
Pericarditis as an interdisciplinary problem. In anticipation of the update of the European Society of Cardiology guidelines
by: Massimo Imazio, et al.
Published: (2024-09-01) -
Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature
by: Vinay Kumar Thallapally, et al.
Published: (2021-07-01) -
Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?
by: François Roubille, et al.
Published: (2022-06-01) -
Emerging Therapies for Recurrent Pericarditis: Interleukin‐1 inhibitors
by: Saberio Lo Presti, et al.
Published: (2021-10-01) -
Efficacy and safety of anakinra in radiation-induced acute pericarditis: a case report
by: Ludovico Luca Sicignano, et al.
Published: (2024-10-01)